Information about Prostate Cancer
Prostate Cancer
Prostate cancer is a disease in which malignant cells (cancer) form in the tissues of the prostate. The prostate is a gland in the male reproductive system located below the bladder and in front of the rectum. It is about the size of a walnut and surrounds the urethra (the tube through which urine flows from the bladder to the outside). The prostate produces a fluid that makes up part of the semen.
According to the National Cancer Institute, prostate cancer is the second most common form of cancer affecting men in the United States. Approximately 221,000 men in the United States were diagnosed with prostate cancer in 2003. More than seventy percent of men diagnosed with prostate cancer each year are over the age of 65.

In Central America and the Caribbean, prostate cancer is the leading cause of cancer mortality in men. Incidence and mortality rates for prostate cancer vary between countries. The highest mortality and incidence rates for prostate cancer occur in the Caribbean, with Barbados, Trinidad and Tobago and Guyana standing out.
The lowest mortality rates for this type of cancer occur in the United States and Canada, despite their high incidence rates.
There are no observable symptoms of prostate cancer while in the early stages. In more advanced stages, symptoms include urinary difficulty or frequency, blood in the urine or bone pain.
Unfortunately, there are no symptoms of early prostate cancer. When the prostate begins to swell due to a tumor and/or cancer has spread, some of the following symptoms may be experienced:
- Frequent or uncontrollable urination
- Complications when attempting to start or stop the flow of urine
- Urine leakage during bodily contractions
- Painful burning sensation upon urination and/or ejaculation
- Blood in urine and/or semen
- Swelling of the lower extremities of the body
- Sudden weakness or paralysis of the lower extremities
The growth of cancer in the prostate creates a blockage, which can lead to symptoms like these. The cancer itself does not cause these symptoms. However, if you are experiencing any of these symptoms, call your doctor to discuss them further.
Regular screening and detection can identify prostate cancer in its early stages. Early identification of prostate cancer allows for early treatment resulting in fewer side effects, treatment with a better prognosis, and a greater chance of being cured.
Risk factors associated with Prostate Cancer
A risk factor is anything that affects the likelihood that you will get a disease. However, having one or even several risk factors does not mean you will get the disease. Researchers have discovered several risk factors that can affect a man's risk of prostate cancer.
The risk of prostate cancer increases with age. It is rare for prostate cancer to develop in men under 40 years of age; in most cases it occurs in men over 65 years of age.
AGE
Theoretically, all men are at risk of developing prostate cancer. As age increases, the likelihood of developing prostate cancer is higher. It is very rare in men under 40 (where the rate of prostate cancer is only 1 in 10,000), however, the rate of men diagnosed with prostate cancer rises rapidly to 1 in 38 for men between 40 to 59 and even higher at 1 in 14 for ages 60 to 69. Statistically speaking, men over the age of 65 account for more than 65% of all men diagnosed with prostate cancer. However, this does not completely eliminate men in their 30s or even younger from being at risk for prostate cancer.
RACE / ETHNICITY
Prostate cancer occurs more often in black men and Caribbean men of African descent than in men of other races. Black men are also more than twice as likely to die from prostate cancer as white men. Prostate cancer occurs less often in Asian-American and Hispanic/Latino men than in white men. The reasons for these racial and ethnic differences are unclear.
GEOGRAPHY
The geographic area where you live can have a huge effect on the risk of developing prostate cancer. Men residing in North America, northwestern Europe, Australia and the Caribbean islands are at higher risk of developing prostate cancer, and it is less common in men in Asia, Africa, Central America and South America. For example, the risk of developing prostate cancer in men residing in the United States is 17% versus a 2% risk for men living in rural China. However, when men from countries such as China move to Western culture, the risk of developing prostate cancer increases substantially. The factors contributing to these dramatic changes in prostate cancer risk have not yet been determined. Hispanic men have a risk similar to that of the general population, although the death rate from this disease has not declined in recent years as it has in Caucasian and African-American men.
GENETICS / FAMILY HISTORY
Prostate cancer occurs more often in black men and Caribbean men of African descent than in men of other races. Black men are also more than twice as likely to die from prostate cancer as white men. Prostate cancer occurs less often in Asian-American and Hispanic/Latino men than in white men. The reasons for these racial and ethnic differences are unclear.
DIET
Several diet-related factors have been studied in recent years to better understand their role in affecting the risk of developing prostate cancer. Men who eat rice, vegetables and soy products have been shown to be less likely to be diagnosed with prostate cancer while men who tend to eat a lot of red meat or high-fat dairy products appear to have a higher chance of developing prostate cancer. These men also tend to eat less fruits and vegetables. Doctors and scientists have not reached conclusive results as to which of these factors are actually responsible for raising the risk of prostate cancer.
Obese men - those whose body mass index is greater than 32.5 - are 33% more likely to die from prostate cancer.
The prostate is a walnut-sized gland located in front of the rectum, below the bladder and surrounding the urethra. Its main purpose is to produce fluid that transports sperm during male orgasm. According to recent estimates, between 180,000 and 200,000 new cases of prostate cancer are detected annually.
Frequently asked questions related to prostate cancer
The prostate is a walnut-sized gland located in front of the rectum, below the bladder and surrounding the urethra. Its main function is to produce fluid that transports sperm during male orgasm. According to recent estimates, there are 180,000 to 200,000 newly diagnosed cases of prostate cancer detected annually.
Prostate cancer is the second leading cause of cancer death in men after lung cancer. In the United States, approximately 40,000 men die as a result of prostate cancer each year. Prostate cancer is characterized by uncontrolled growth and possible spread of abnormal cells.
- console surgeon
- Next to the purchase patient
- Insite Vision System
The Insite Vision System provides a 3D view of the surgical field, a significant improvement over the 2D view of laparoscopic surgery. This translates into a much better field of view and improved depth perception. High-definition video cameras offer 10X to 15X magnification, a view that the surgeon could never obtain with traditional surgery. This is particularly important in visualizing the prostate capsule, preserving the neurovascular bundles responsible for erectile function and reconnecting the urethra to the bladder.
There are three surgical options to remove the entire prostate gland. These options are for patients with early diagnosed organ-confined prostate cancer.
- Robotic Radical Prostatectomy
- Laparoscopic Radical Prostatectomy
- Traditional Open Radical Prostatectomy
Men who are diagnosed with localized prostate cancer are candidates for this procedure. Most patients who are candidates for open surgery would have excellent results with this procedure. The indications for this surgery are similar to those for open surgery.
Definitely not, the robot is completely under the surgeon's control. The robot allows the surgeon to operate in small spaces in the abdomen.
It is a rare incident, occurring once in the last three years. During that incident the intervention is completed through laparoscopic surgery without the need to perform an insicion and open the patient's abdomen. It is important to be trained in open surgery, laparoscopy and robotic surgery for this very reason.
The catheter is removed five days after surgery.
It usually takes between 2.5 to 3 hours depending on the anatomy of the prostate and the patient's habits.
Laparoscopic radical prostatectomy is a minimally invasive surgical treatment for prostate cancer. It consists of a few small incisions to remove the prostate completely.
Radical retropubic prostatectomy is a surgical removal of the prostate, seminal vesicle and the entrained vessel through a lower abdominal incision.
- Short hospital stay
- Reduced blood loss
- Early catheter removal
- After surgery, minimal requirement for pain medications
- 10 to 15 times magnification of the doctor's vision
- Return to normal activities one to two weeks after surgery
- Improved cosmetic results
The cancer control outcomes in patients who underwent laparoscopy are essentially identical to patients who underwent open prostatectomy. Most institutions across the country where this procedure is routinely performed can confirm this.
It usually lasts between 2.5 to 3.5 hours. Each case is different due to the size of the prostate and different anatomies. It is comparable to the estimated time in open surgeries.
Most patients are discharged the day after surgery. However, the timing is decided on a case-by-case basis. By the second night, more than 90 percent of patients are comfortable at home.
In open surgeries, the catheter is removed after two to three weeks. However, with laparoscopic prostatectomy, the catheter is removed three days after surgery. This removal is performed in our offices under X-ray control to verify the state of the anastomosis.
The average blood loss with this procedure is 150cc. That is why the risk of having to receive blood transfusions is minimal. The blood vessels collapse due to the high abdominal pressure and are controlled as a result of the visual magnification achieved with the use of the camera.
Every effort is made to save these nerves. One of the main advantages of this procedure is the fact that both nerves and vessels are enlarged and as a consequence it is easier to save them. It can take up to 6 months to regain sexual potency and in some individual cases, the intake of Viagra helped the patients significantly.
During the first few weeks you will need to wear pads. Continence will return within a few weeks, over 95 percent of patients have full control of urination. Occasionally, I have seen patients with stress incontinence after surgery which usually resolves with Kegel exercises.
Prostate Cancer Screening
There are 2 tests that can detect prostate cancer:
- A blood test to measure prostate-specific antigen (PSA) levels. Annual cancer screening should begin at age 50 for the general population, although the age to begin screening depends on a person's level of risk.
- Un examen físico de la próstata y un examen rectal digital (DRE). El examen rectal digital es un examen físico, rápido e indoloro, donde el doctor busca anomalías en la superficie de la próstata que puedan significar un creciente tumor. El término “digital” se refiere al uso de un dedo lubricado para llevar a cabo el examen.
"Both tests should be performed simultaneously to increase diagnostic accuracy."
Considerations for prostate cancer screening:
- Annual studies should begin at age 50 for the general male population.
- Men with at least one risk factor should begin annual screening at age 45.
- Men who present more than one risk factor should begin annual studies at the age of 40.
- Some men decide to take an isolated test at a younger age, 35 or 40 years, to obtain a PSA (prostate specific antigen) level, thus establishing a level for future comparisons.
Where to perform the studies to diagnose prostate cancer:
- Your primary care physician can perform both the PSA (prostate-specific antigen) test and the physical examination.
- If you cannot afford a medical consultation, contact the hospital or clinic in your area to inquire about free examinations.
Interpretation of Results based on the General PSA Standard
- Normal - 0.0-4.0 nanograms / milliliter - considered safe
- Intermediate - 4.1-9.9 nanograms/milliliter - considered safe, but may suggest the possibility of prostate cancer so talk to your doctor.
- High - 10.0 + nanograms/milliliter - is considered dangerous and you should talk to your doctor immediately.
Significance of high PSA levels
An elevated PSA alone does not automatically mean prostate cancer is present. Digital rectal examination (DRE) should always accompany a PSA blood test as they detect prostate problems, such as cancer, when used together.
Higher PSA levels may be caused due to:
- Older age, older age
- Prostate lesion
- Prostatitis
- Pressure in the penile area up to the rectum
- Sex within 24 hours of PSA sample collection
- Urinary tract infection
- Testosterone supplements
- Significance of low PSA levels
- In general, a low level is positive. However, even men diagnosed with prostate cancer may have low PSA levels due to dilution.
Prostate Cancer Prevention
As of today there is no single cause for prostate cancer, therefore, a preventive strategy has not yet been developed. For this reason, education and awareness for prostate cancer is ever so vital for men and women, sons, brothers, family and friends of men facing prostate cancer.

Being well informed, aware of all prostate cancer risk factors and taking any necessary action to maintain or improve health through diet and exercise are extremely important.
An annual screening for prostate cancer is highly recommended because, if detected early, the chances of elimination increase.
By adopting a healthy lifestyle, which consists of regular exercise and limiting consumption of saturated fat found in red meat and dairy products, the risk can be reduced.
Studies show a strong connection between saturated fat consumption and increased prostate cancer diagnosis and mortality rates. Diets rich in nutrients such as vitamin E, selenium, soy, green tea and tomatoes appear to reduce the risk of prostate cancer. Studies are ongoing to confirm these findings, and more cancer-fighting nutrients are constantly being discovered and studied.
Living with Prostate Cancer
Recent diagnosis
You are probably here because you or someone you care about has recently been diagnosed with prostate cancer. It is normal to have fears and questions. Please use this section to help guide and educate about prostate cancer.

Prostate cancer is usually slow growing but once you have been diagnosed, it is important to learn as much as possible, consider all your options, and create a plan. The five-year survival rate is nearly 100% so don't give up. Always talk to your doctor and thoroughly discuss the options available to you.
You can start here:
- Better understanding of the diagnosis
- Learn more about the treatment options available to you, as well as the advantages and disadvantages of each treatment.
- Feel free to ask any questions directly to Dr. David Samadi, via the contact specified on this website.
You are not alone
Prostate cancer is treatable and manageable so have hope and never give up. There are many options to explore, but always the best way is to educate yourself as much as possible and talk to your doctor to create a plan. Active vigilance and expectant behavior is a must.
Routine prostate cancer monitoring should be kept closely through various scheduled tests, such as PSA, DRE, and ultrasound. Prostate biopsies may also be options in order to make sure that the cancer is not becoming more aggressive. Simply monitoring for any changes in symptoms is a less intensive method that will help you decide what further treatment is needed.
There are several methods of treatment for prostate cancer: surgery and radiation therapy. Once you have been diagnosed, it is vital that you work with your doctor to determine which treatment option is best for you.
The options of treatment for men with prostate cancer include:
RADIATION THERAPY
Radiation therapy refers to the use of high-energy x-rays or other types of radiation. Radiation therapy for the treatment of prostate cancer kills cancer cells or may limit the growth of these cancer cells.
When men are treated with radiation therapy for prostate cancer, they increase the risk of having bladder and/or colon cancer by 2-5%. Radiation therapy can also cause impotence, urinary problems, and over time can lead to inflammation of surrounding tissues.
If the patient has previously received radiation treatment, he/she will not be a candidate for the surgical procedure.
CyberKnife
Although there is insufficient long-term data available to support the efficacy of this treatment, the CyberKnife robotic radiosurgery system is a non-surgical procedure that delivers high doses of radiation to the prostate in several prostate treatment sessions called stereotactic body radiation therapy.
Side effects may include erectile dysfunction, urinary retention, and injury to the walls of the rectum or bladder.
HIFU
High Intensity Ultrasound (HIFU) is a new and lesser known technique that applies heat (85°-95°C) to the prostate gland through an endorectal probe in order to destroy the cancer. Due to the lack of data and history of this treatment, the true efficacy is still unclear.
The options of SURGERY for men with prostate cancer:
With surgery the physician is able to obtain the most accurate staging of prostate cancer. The surgery options available are as follows:
Radical prostatectomy (OPEN)
Under anesthesia, a skin incision is made in the lower abdomen or perineum and the prostate cancer is removed. Sometimes lymph nodes may also be removed for laboratory testing for cancer cells. This open surgery usually results in significant blood loss, a long and uncomfortable recovery and presents a high risk of impotence and incontinence. This is not the preferred treatment for treating prostate cancer considering the alternatives available, e.g., robotic laparoscopic prostatectomy or Vinci robotic prostatectomy.
Laparoscopic radical prostatectomy (LRP)
One of the most common treatments for prostate cancer, which consists of removing the prostate gland, is known as laparoscopic prostatectomy or radical prostatectomy. Traditional radical prostatectomy requires a 20 to 25 centimeter incision. Under anesthesia, several small incisions are made in the skin and special surgical tools are used to remove the cancerous prostate. With one of these tools equipped with a special video camera to provide the surgeon with direct visuals, the surgeon holds and maneuvers the other tools by hand and removes the cancer.
Robotic-assisted laparoscopic radical prostatectomy (RALRP)
The da Vinci robotic prostatectomy is the ultimate in minimally invasive surgery, offering the latest advances in robotics and computer technology for a prostate cancer patient.
The robotic prostatectomy incorporates a modern surgical system that enables a surgical procedure with low risks, minimal side effects and a rapid recovery for patients.
Although each patient is treated on a case-by-case basis, when opting for surgery, da Vinci robotic prostatectomy is the preferred method over all others, as it allows experienced surgeons, such as Dr. David Samadi, greater visibility, maneuverability and precision when removing prostate cancer and has the most important advantages for the patient, such as:
- Faster recovery Keyhole-shaped incisions
- Rapid healing
- Minimal transfusion
- Limited pain
- Small scars
- Less cauterization
- Minimal blood loss
- Minimal risk of developing impotence or incontinence
- Shorter hospital stay Low risk of infection